Никонов Е.Л., Попова Е.Н. (ред.). Микробиота. М.: Медиа Сфера; 2019. 255 с. Режим доступа: https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/.https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/
Никонов Е.Л., Попова Е.Н. (ред.). Микробиота. М.: Медиа Сфера; 2019. 255 с. Режим доступа: https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/.https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/
Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.3..
DOI: 10.1371/journal.pbio.1002533.3
Tanaka M., Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66(4):515–522. doi: 10.1016/j.alit.2017.07.010..
DOI: 10.1016/j.alit.2017.07.010
Dunn A.B., Jordan S., Baker B.J., Carlson N.S. The Maternal Infant Microbiome: Considerations for Labor and Birth. MCN Am J Matern Child Nurs. 2017;42(6):318–325. doi: 10.1097/NMC.0000000000000373..
DOI: 10.1097/NMC.0000000000000373
Bäckhed F., Roswall J., Peng Y., Feng Q., Jia H., Kovatcheva-Datchary P. et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015;17(6):852. doi: 10.1016/j.chom.2015.04.004..
DOI: 10.1016/j.chom.2015.04.004
Matsuki T., Yahagi K., Mori H., Matsumoto H., Hara T., Tajima S. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun. 2016;7:11939. doi: 10.1038/ncomms11939..
DOI: 10.1038/ncomms11939
Nuriel-Ohayon M., Neuman H., Koren O. Microbial Changes during Pregnancy, Birth, and Infancy. Front Microbiol. 2016;7:1031. doi: 10.3389/fmicb.2016.01031..
DOI: 10.3389/fmicb.2016.01031
Gensollen T., Iyer S.S., Kasper D.L., Blumberg R.S. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–544. doi: 10.1126/science.aad9378..
DOI: 10.1126/science.aad9378
Thursby E., Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–1836. doi: 10.1042/BCJ20160510..
DOI: 10.1042/BCJ20160510
Adair K.L., Douglas A.E. Making a microbiome: the many determinants of host-associated microbial community composition. Curr Opin Microbiol. 2017;35:23–29. doi: 10.1016/j.mib.2016.11.002..
DOI: 10.1016/j.mib.2016.11.002
Hall A.B., Tolonen A.C., Xavier R.J. Human genetic variation and the gut microbiome in disease. Nat Rev Genet. 2017;18(11):690–699. doi: 10.1038/nrg.2017.63..
DOI: 10.1038/nrg.2017.63
Abdul-Aziz M.A., Cooper A., Weyrich L.S. Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies. Front Microbiol. 2016;7:1611. doi: 10.3389/fmicb.2016.01611..
DOI: 10.3389/fmicb.2016.01611
Harmsen H.J. M., de Goffau M.C. The Human Gut Microbiota. Adv Exp Med Biol. 2016;902:95–108. doi: 10.1007/978-3-319-31248-4_7..
DOI: 10.1007/978-3-319-31248-4_7
Jandhyala S.M., Talukdar R., Subramanyam C., Vuyyuru H., Sasikala M., Reddy D.N. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787–803. doi: 10.3748/wjg.v21.i29.8787..
DOI: 10.3748/wjg.v21.i29.8787
Lloyd-Price J., Abu-Ali G., Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. doi: 10.1186/s13073-016-0307-y..
DOI: 10.1186/s13073-016-0307-y
Shafquat A., Joice R., Simmons S.L., Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol. 2014;22(5):261–266. doi: 10.1016/j.tim.2014.01.011..
DOI: 10.1016/j.tim.2014.01.011
Nagai M., Obata Y., Takahashi D., Hase K. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis. Int Immunopharmacol. 2016;37:79–86. doi: 10.1016/j.intimp.2016.04.001..
DOI: 10.1016/j.intimp.2016.04.001
Flint H.J., Duncan S.H., Scott K.P., Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015;74(1):13–22. doi: 10.1017/S0029665114001463..
DOI: 10.1017/S0029665114001463
Meng X., Zhang G., Cao H., Yu D., Fang X., Vos W.M., Wu H. Gut dysbacteriosis and intestinal disease: mechanism and treatment. J Appl Microbiol. 2020;129(4):787–805. doi: 10.1111/jam.14661..
DOI: 10.1111/jam.14661
Gagliardi A., Totino V., Cacciotti F., Iebba V., Neroni B., Bonfiglio G. et al. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health. 2018;15(8):1679. doi: 10.3390/ijerph15081679..
DOI: 10.3390/ijerph15081679
Bäumler A.J., Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85–93. doi: 10.1038/nature18849..
DOI: 10.1038/nature18849
Amabebe E., Robert F.O., Agbalalah T., Orubu E.S. F. Microbial dysbiosisinduced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123(10):1127–1137. doi: 10.1017/S0007114520000380..
DOI: 10.1017/S0007114520000380
Kwak M.J., Kwon S.K., Yoon J.K., Song J.Y., Seo J.G., Chung M.J., Kim JF. Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function. Syst Appl Microbiol. 2016;39(7):429–439. doi: 10.1016/j.syapm.2016.07.004..
DOI: 10.1016/j.syapm.2016.07.004
Shang M., Sun J. Vitamin D/VDR, probiotics, and gastrointestinal diseases. Curr Med Chem. 2017;24(9):876–887. doi: 10.2174/0929867323666161202150008..
DOI: 10.2174/0929867323666161202150008
Yamamoto E.A., Jørgensen T.N. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol. 2020;10:3141. doi: 10.3389/fimmu.2019.03141..
DOI: 10.3389/fimmu.2019.03141
Celiberto L.S., Bedani R., Rossi E.A., Cavallini D.C. U. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr. 2017;57(9):1759–1768. doi: 10.1080/10408398.2014.941457..
DOI: 10.1080/10408398.2014.941457
Tidjani Alou M., Lagier J.-C., Raoult D. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Hum Microbiome J. 2016;1:3–11. doi: 10.1016/j.humic.2016.09.001..
DOI: 10.1016/j.humic.2016.09.001
Magruder M., Sholi A.N., Gong C., Zhang L., Edusei E., Huang J. et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. doi: 10.1038/s41467-019-13467-w..
DOI: 10.1038/s41467-019-13467-w
Forbes J.D., Van Domselaar G., Bernstein C.N. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol. 2016;7:1081. doi: 10.3389/fmicb.2016.01081..
DOI: 10.3389/fmicb.2016.01081
Simpson H.L., Campbell B.J. Review article: dietary fibre – microbiota interactions. Aliment Pharmacol Ther. 2015;42(2):158–179. doi: 10.1111/apt.13248..
DOI: 10.1111/apt.13248
Filippis F.D., Pellegrini N., Vannini L., Jeffery I.B., Storia A.L., Laghi L. et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65(11):1812–1821. doi: 10.1136/gutjnl-2015-309957..
DOI: 10.1136/gutjnl-2015-309957
Sakkas H., Bozidis P., Touzios C., Kolios D., Athanasiou G., Athanasopoulou E. et al. Nutritional Status and the Influence of the Vegan Diet on the Gut Microbiota and Human Health. Medicina (Kaunas). 2020;56(2):88. doi: 10.3390/medicina56020088..
DOI: 10.3390/medicina56020088
David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi: 10.1038/nature12820..
DOI: 10.1038/nature12820
Murphy E.A., Velazquez K.T., Herbert K.M. Influence of High-Fat-Diet on Gut Microbiota: A Driving Force for Chronic Disease Risk. Curr Opin Clin Nutr Metab Care. 2015;18(5):515–520. doi: 10.1097/MCO.0000000000000209..
DOI: 10.1097/MCO.0000000000000209
Smith-Brown P., Morrison M., Krause L., Davies P.S. W. Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Sci Rep. 2016;6:32385. doi: 10.1038/srep32385..
DOI: 10.1038/srep32385
Arrieta M.-C., Stiemsma L.T., Dimitriu P.A., Thorson L., Russell S., YuristDoutsch S. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152. doi: 10.1126/scitranslmed.aab2271..
DOI: 10.1126/scitranslmed.aab2271
Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi: 10.1038/nrgastro.2014.66..
DOI: 10.1038/nrgastro.2014.66
Sebastián Domingo J.J. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol. 2017;40(6):417–429. doi: 10.1016/j.gastrohep.2016.12.003..
DOI: 10.1016/j.gastrohep.2016.12.003
Daliri E., Lee B.H. New perspectives on probiotics in health and disease. Food Sci Hum Wellness. 2015;4(2):56–65. doi: 10.1016/j.fshw.2015.06.002..
DOI: 10.1016/j.fshw.2015.06.002
Guarner F., Sanders M.E., Eliakim R., Fedorak R., Gangl A., Garisch J. et al. Probiotics and prebiotics. World Gastroenterology Organisation. 2017. Available at: https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english
Guarner F., Sanders M.E., Eliakim R., Fedorak R., Gangl A., Garisch J. et al. Probiotics and prebiotics. World Gastroenterology Organisation. 2017. Available at: https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english
Ouwehand A.C., Forssten S., Hibberd A.A., Lyra A., Stahl B. Probiotic approach to prevent antibiotic resistance. Ann Med. 2016;48(4):246–255. doi: 10.3109/07853890.2016.1161232..
DOI: 10.3109/07853890.2016.1161232
Korpela K., Salonen A., Virta L.J., Kumpu M., Kekkonen R.A., de Vos W.M. Lactobacillus rhamnosus GG Intake Modifies Preschool Children’s Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. PLoS One. 2016;11(4):e0154012. doi: 10.1371/journal.pone.0154012..
DOI: 10.1371/journal.pone.0154012
Ivashkin V.T., Mayev I.V., Abdulganieva D.I., Alekseenko S.A., Ivashkina N.Yu., Korochanskaya N.V. et al. Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults. Rossiyskiy zhurnal gastroehnterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(2):76–89. (In Russ.) doi: 10.22416/1382-4376-2020-30-2-76-89..
DOI: 10.22416/1382-4376-2020-30-2-76-89
Yoo J.Y., Kim S.S. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients. 2016;8(3):173. doi: 10.3390/nu8030173..
DOI: 10.3390/nu8030173
Sun J., Buys N. Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Ann Med. 2015;47(6):430–440. doi: 10.3109/07853890.20 15.1071872..
DOI: 10.3109/07853890.20 15.1071872
Kim C.J., Walmsley S.L., Raboud J.M., Kovacs C., Coburn B., Rousseau R. et al. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. HIV Clin Trials. 2016;17(4):147–157. doi: 10.1080/15284336.2016.1184827..
DOI: 10.1080/15284336.2016.1184827
Cani P.D., Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol. 2015;32:21–27. doi: 10.1016/j.copbio.2014.10.006..
DOI: 10.1016/j.copbio.2014.10.006
Patel R., DuPont H.L. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(2 Suppl.):108–121. doi: 10.1093/cid/civ177..
DOI: 10.1093/cid/civ177
Martín R., Miquel S., Benevides L., Bridonneau C., Robert V., Hudault S. et al. Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic. Front Microbiol. 2017;8:1226. doi: 10.3389/fmicb.2017.01226..
DOI: 10.3389/fmicb.2017.01226
Cani P.D., Everard A. Akkermansia muciniphila: a novel target controlling obesity, type 2 diabetes and inflammation? Med Sci (Paris). 2014;30(2):125–127. (In French) doi: 10.1051/medsci/20143002003..
DOI: 10.1051/medsci/20143002003
Schneeberger M., Everard A., Gómez-Valadés A.G., Matamoros S., Ramírez S., Delzenne N.M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. doi: 10.1038/srep16643..
DOI: 10.1038/srep16643
Miller L.E., Ouwehand A.C., Ibarra A. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Ann Gastroenterol. 2017;30(6):629–639. doi: 10.20524/aog.2017.0192..
DOI: 10.20524/aog.2017.0192
Asha M.Z., Khalil S.F. H. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome. Sultan Qaboos Univ Med J. 2020;20(1):e13–24. doi: 10.18295/squmj.2020.20.01.003..
DOI: 10.18295/squmj.2020.20.01.003
Derwa Y., Gracie D.J., Hamlin P.J., Ford A.C. Systematic review with metaanalysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(4):389–400. doi: 10.1111/apt.14203..
DOI: 10.1111/apt.14203
Ganji‐Arjenaki M., Rafieian‐Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233(3):2091–2103. doi: 10.1002/jcp.25911..
DOI: 10.1002/jcp.25911
Oka A., Sartor R.B. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Dig Dis Sci. 2020;65(3):757–788. doi: 10.1007/s10620-020-06090-z..
DOI: 10.1007/s10620-020-06090-z
Luthold R.V., Fernandes G.R., Franco-de-Moraes A.C., Folchetti L.G. D., Ferreira S.R. G. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76–86. doi: 10.1016/j.metabol.2017.01.007..
DOI: 10.1016/j.metabol.2017.01.007
Yacoub R., Kaji D., Patel S.N., Simoes P.K., Busayavalasa D., Nadkarni G.N. et al. Association between probiotic and yogurt consumption and kidney disease: insights from NHANES. Nutr J. 2016;15:10. doi: 10.1186/s12937-016-0127-3..
DOI: 10.1186/s12937-016-0127-3
Firouzi S., Haghighatdoost F. The effects of prebiotic, probiotic, and synbiotic supplementation on blood parameters of renal function: A systematic review and meta-analysis of clinical trials. Nutrition. 2018;51–52:104–113. doi: 10.1016/j.nut.2018.01.007..
DOI: 10.1016/j.nut.2018.01.007
Hadi A., Mohammadi H., Miraghajani M., Ghaedi E. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Crit Rev Food Sci Nutr. 2019;59(15):2494–2505. doi: 10.1080/10408398.2018.1458021..
DOI: 10.1080/10408398.2018.1458021
Kristensen N.B., Bryrup T., Allin K.H., Nielsen T., Hansen T.H., Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8(1):52. doi: 10.1186/s13073-016-0300-5..
DOI: 10.1186/s13073-016-0300-5
Satokari R. Modulation of Gut Microbiota for Health by Current and NextGeneration Probiotics. Nutrients. 2019;11(8):1921. doi: 10.3390/nu11081921..
DOI: 10.3390/nu11081921
Sanders M.E. Probiotics and microbiota composition. BMC Med. 2016;14(1):82. doi: 10.1186/s12916-016-0629-z..
DOI: 10.1186/s12916-016-0629-z
Falony G., Joossens M., Vieira-Silva S., Wang J., Darzi Y., Faust K. et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560–564. doi: 10.1126/science.aad3503..
DOI: 10.1126/science.aad3503
Mullish B.H., Quraishi M.N., Segal J.P., McCune V. L., Baxter M., Marsden G.L. et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67(11):1920–1941. doi: 10.1136/gutjnl-2018-316818..
DOI: 10.1136/gutjnl-2018-316818
Saha S., Mara K., Pardi D.S., Khanna S. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 2021;(April 08). (In press) doi: 10.1053/j.gastro.2021.01.010..
DOI: 10.1053/j.gastro.2021.01.010
Grehan M.J., Borody T.J., Leis S.M., Campbell J., Mitchell H., Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010;44(8):551–561. doi: 10.1097/MCG.0b013e3181e5d06b..
DOI: 10.1097/MCG.0b013e3181e5d06b
Blanchaert C., Strubbe B., Peeters H. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol Belg. 2019;82(4):519–528. Available at: https://pubmed.ncbi.nlm.nih.gov/31950808/.https://pubmed.ncbi.nlm.nih.gov/31950808/
Blanchaert C., Strubbe B., Peeters H. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol Belg. 2019;82(4):519–528. Available at: https://pubmed.ncbi.nlm.nih.gov/31950808/.https://pubmed.ncbi.nlm.nih.gov/31950808/
Sokol H., Landman C., Seksik P., Berard L., Montil M., Nion-Larmurier I. et al. Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study. Microbiome. 2020;8(1):12. doi: 10.1186/s40168-020-0792-5..
DOI: 10.1186/s40168-020-0792-5
Caldeira L.F., Borba H.H., Tonin F.S., Wiens A., Fernandez-Llimos F., Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One. 2020;15(19):e0238910. doi: 10.1371/journal.pone.0238910..
DOI: 10.1371/journal.pone.0238910
El-Salhy M., Mazzawi T. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2018;12(5):439–445. doi: 10.1080/17474124.2018.1447380..
DOI: 10.1080/17474124.2018.1447380
Xu D., Chen V.L., Steiner C.A., Berinstein J.A., Eswaran S., Waljee A.K. et al. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019;114(7):1043–1050. doi: 10.14309/ajg.0000000000000198..
DOI: 10.14309/ajg.0000000000000198
Ianiro G., Eusebi L.H., Black C.J., Gasbarrini A., Cammarota G., Ford A.C. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(3):240–248. doi: 10.1111/apt.15330..
DOI: 10.1111/apt.15330
Myneedu K., Deoker A., Schmulson M.J., Bashashati M. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis. United European Gastroenterol J. 2019;7(8):1033–1041. doi: 10.1177/2050640619866990..
DOI: 10.1177/2050640619866990
Kao D., Roach B., Park H., Hotte N., Madsen K., Bain V., Tandon P. Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology. 2016;63(1):339–340. doi: 10.1002/hep.28121..
DOI: 10.1002/hep.28121
Bajaj J.S., Kassam Z., Fagan A., Gavis E.A., Liu E., Cox I.J. et al. Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial. Hepatology. 2017;66(6):1727–1738. doi: 10.1002/hep.29306..
DOI: 10.1002/hep.29306
Bajaj J.S., Salzman N.H., Acharya C., Sterling R.K., White M.B., Gavis E.A. et al. Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. Hepatology. 2019;70(5):1690–1703. doi: 10.1002/hep.30690..
DOI: 10.1002/hep.30690
Vemuri R., Shankar E.M., Chieppa M., Eri R., Kavanagh K. Beyond Just Bacteria: Functional Biomes in the Gut Ecosystem Including Virome, Mycobiome, Archaeome and Helminths. Microorganisms. 2020;8(4):483. doi: 10.3390/microorganisms8040483..
DOI: 10.3390/microorganisms8040483
DeFilipp Z., Bloom P.P., Soto M.T., Mansour M.K., Sater M.R. A., Huntley M. H et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019;381(21):2043–2050. doi: 10.1056/NEJMoa1910437..
DOI: 10.1056/NEJMoa1910437
Cammarota G., Ianiro G., Tilg H., Rajilić-Stojanović M., Kump P., Satokari R. et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569–580. doi: 10.1136/gutjnl-2016–313017..
DOI: 10.1136/gutjnl-2016–313017